黑色素瘤疫苗临床研究进展
被引量：1
Clinical advances of melanoma vaccines
摘要
黑色素瘤疫苗是将携带有黑色素瘤相关抗原的自体或异体肿瘤细胞、裂解物、肽、基因等接种到机体,或结合热休克蛋白、树突状细胞等,刺激并增强机体免疫系统对肿瘤细胞的免疫应答,是黑色素瘤的辅助治疗手段。现综述近年来黑色素瘤疫苗的临床研究进展。
出处
《国外医学（肿瘤学分册）》
2005年第12期951-954,共4页
Foreign Medical Sciences (Cancer Section)
参考文献23
-
1Schadendorf D, Paschen A, Sun Y. Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma.Immunol Lett,2000,74 ( 1 ) :67-74.
-
2Wolohok JD,Livingston PO. Vaccines for melanoma:translating basic immunology into new therapies. Lancet Oncol, 2001,2 ( 4 ) : 205 - 211.
-
3Ragupathi G, Meyers M, Adluri S, et al. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. Int J Cancer,2000,85 ( 5 ) :659-666.
-
4Ragupathi G, Livingston PO, Hood C, et al. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21. Clin Cancer Res, 2003,9 (14) : 5214-5220.
-
5Foon KA, Lutzky J, Baral RN, et al. Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. J Clin Oncol,2000,18(2) :376-384.
-
6Chapman PB ,Williams L,Salibi N, et al. A phase Ⅱ trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside. Vaccine, 2004, 22 ( 21-22 ) : 2904-2909.
-
7Wang X, Ko EC, Peng L, et al. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2. Cancer Res,2005,65(15) :6976-6983.
-
8Berd D. Contribution of dead cells to the immunogenicity of an autologous,hapten- modified melanoma vaccine. Vaccine,2003,21 (7-8) :795 -797.
-
9Lotem M, Shiloni E, Pappo I, et al. Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma. Br J Cancer,2004,90(4) :773-780.
-
10Dillman RO, Wiemann M, Nayak SK, et al. Interferon-gamma or graanlocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short- term cell line cultures : a randomized phase 2 trial of the cancer biotherapy research group. J Immunother, 2003,26 ( 4 ) : 367-373.
同被引文献28
-
1崔正军,岑瑛.恶性黑色素瘤基因治疗的研究现状[J].华西医学,2004,19(3):513-514. 被引量：4
-
2KIM C J, DESSUREAULT S, GABRILOVICH D, et al. Immu- notherapy for melanoma [ J ]. Cancer Control, 2002,9 ( 1 ) : 22 - 30.
-
3ODAY S J, KIM C J, REINTGENDS,et al. Metastatic melano- ma: chemotherapy to biochemoth therapy [ J ]. Cancer Control, 2002, 9(1) : 31 -38.
-
4GOGAS H J, KIRKWOOD J M, SONDAK V K. Chemotherapy for metastatic melanoma: time for a change[ J]. Cancer, 2007, 109(3) : 455 -464.
-
5MIDDLETON M R, GROB J J, AARONSON N, et al. Random- ized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melano- ma[ J]. Journal of Clinical Oncology, 2000, 18 ( 1 ) : 156 - 166.
-
6吴红月.靶向药物成黑色素瘤治疗新趋势[N].科技日报,2012-11-08(9).
-
7GROVER R,PACIFICO M D, WILSON G D,et al. Use of on- cogene expression as an independent prognostic marker for pri- mary melanoma[ J]. Annals of Plastic Surgery, 2003, 50 (2) : 183 - 187.
-
8ALONSO - CURBELO D, SOENGAS M S. Self - killing ofmelanoma cells by cytosolic delivery of dsRNA : wiring innate immunity for a coordinated mobilization of endosomes, autopha- gosomes and the apoptotic machinery in tumor cells[ J]. Auto- phagy, 2010, 6(1): 148-150.
-
9DASHR, BHUTIASK, AZAB B, et al. mda-7/IL-24:a unique member of the IL - 10 gene family promoting cancer - targeted toxicity [ J ]. Cytokine Growth Factor Reviews, 2010, 21(5): 381 -391.
-
10UDYAVAR A, GEIGER T L. Rebalancing immune specificity and function in cancer by T - cell receptor gene therapy [ J ]. Archivum Immunologiae et Therapiae Experimentalis, 2010, 58 (5) : 335 -346.
二级引证文献2
-
1刘凯,刘泽强,庄敏丽,潘月海,马占川,刘彬.探索静水高压在研制黑色素瘤疫苗方面的应用[J].中国免疫学杂志,2015,31(8):1077-1081.
-
2魏淑芳,黄斌,孙希希,谢霖霄,黄艳.超声引导下穿刺活检诊断肝脏转移性恶性黑色素瘤的效果分析[J].中国现代医生,2016,54(27):118-120. 被引量：1
-
1张莹莹(综述),耿传营(审校),唐劲天(审校).黑色素瘤疫苗研究进展[J].国际肿瘤学杂志,2009,36(3):181-184.
-
2金伟秋（摘）.Transgene与美国NCI合作开发癌症疫苗[J].国外药讯,2007(2):38-38.
-
3吴静,黄俊星,赵国军,詹树东,卢婷,周彤敏,于鸿.食管鳞癌组织中黑色素瘤相关抗原D4b的表达及临床意义[J].现代肿瘤医学,2015,23(15):2132-2135. 被引量：2
-
4刘凯,刘泽强,庄敏丽,潘月海,马占川,刘彬.探索静水高压在研制黑色素瘤疫苗方面的应用[J].中国免疫学杂志,2015,31(8):1077-1081.
-
5付骏,闭水清,张庆梅,罗彬,陈芳,农蔚霞,石蕾,肖绍文,谢小薰.MAGE-D4在人脑膜瘤组织中的表达及其意义[J].中国癌症防治杂志,2015,7(3):192-195. 被引量：2
-
6黄进（编译）.gp100：209—217[J].中国处方药,2009(5):17-17. 被引量：1
-
7曹克鑫,温丰标,吴恺,韩高扬,赵松,齐宇.人类黑色素瘤相关抗原A9在人食管鳞状细胞癌中的表达及其与预后的关系[J].中华实验外科杂志,2015,32(8):1820-1822. 被引量：3
-
8于静,朱艳华,阎雪莹.黑色素瘤治疗方法的研究[J].哈尔滨商业大学学报（自然科学版）,2014,30(3):266-270. 被引量：2
-
9郭丽丽,刘林嶓,王刚成.小鼠恶性黑色素瘤MCP-1趋化型肿瘤疫苗的研究[J].中华临床医师杂志（电子版）,2015,9(9):96-99.
-
10顾春燕,仇笛,姚建国.肝血管平滑肌脂肪瘤的临床病理分析[J].南通大学学报（医学版）,2006,26(4):257-258. 被引量：1
